|
HS Code |
304808 |
| Iupac Name | diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Molecular Formula | C13H19NO4 |
| Molar Mass | 253.29 g/mol |
| Appearance | yellow solid |
| Melting Point | 100-102°C |
| Solubility In Water | slightly soluble |
| Boiling Point | Decomposes before boiling |
| Cas Number | 844-75-7 |
| Density | 1.19 g/cm3 (estimated) |
| Smiles | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC |
| Pubchem Cid | 13769 |
| Refractive Index | 1.495 (estimated) |
| Hazard Statements | Irritant |
As an accredited diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 250 g of diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, securely sealed in an amber glass bottle with hazard labeling. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate: typically 12-14 MT packed in 25 kg fiber drums. |
| Shipping | This chemical, diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, should be shipped in tightly sealed containers, protected from light and moisture. Handle with care, following all safety protocols. Ensure compliance with local, national, and international shipping regulations, labeling appropriately. Store at room temperature during transport, away from incompatible substances and ignition sources. |
| Storage | Store **diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate** in a tightly sealed container, protected from light, moisture, and air. Keep at room temperature in a cool, dry, well-ventilated area away from sources of ignition, strong acids, and oxidizers. Proper labeling and containment are essential. Use appropriate personal protective equipment when handling. Store according to local regulations for organic chemicals. |
| Shelf Life | Shelf life of diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate is typically 2-3 years if stored cool, dry, and protected from light. |
|
Purity 98%: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate with purity 98% is used in pharmaceutical intermediate synthesis, where high yield and minimal impurity formation are achieved. Melting point 210°C: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate of melting point 210°C is used in solid-state formulation development, where enhanced thermal stability is maintained during processing. Molecular weight 293.33 g/mol: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate at molecular weight 293.33 g/mol is used in medicinal chemistry research, where precise molecular incorporation enables accurate compound design. Stability temperature up to 120°C: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate with stability up to 120°C is used in controlled reaction conditions, where decomposition is minimized for consistent product quality. Low hygroscopicity: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate of low hygroscopicity is used in dry blend tablet manufacturing, where shelf-life and formulation integrity are improved. Solubility in ethanol: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate soluble in ethanol is used in extraction protocols, where efficient recovery and purification are facilitated. Particle size <50 μm: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate with particle size less than 50 μm is used in rapid dissolution testing, where uniform dispersion increases bioavailability. Assay ≥99%: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate with assay ≥99% is used in active pharmaceutical ingredient formulation, where reproducible potency and efficacy are ensured. UV absorbance (λmax 365 nm): diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate showing UV absorbance at 365 nm is used in spectrophotometric analysis, where quantitative detection and monitoring are optimized. Residual solvent <0.5%: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate with residual solvent content below 0.5% is used in high-purity organic synthesis, where regulatory compliance and process safety are maintained. |
Competitive diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Producing diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate at scale brings us face to face with the questions chemists and industry veterans keep asking: what difference do real manufacturing controls make, what features define material produced for research versus production, and how does purity level reshape outcome and cost? Based on two decades behind reactors, there isn’t a shortcut to consistent quality. Each run draws on detailed analytical work, simple hands-on problem solving, and a kind of muscle memory that comes from lots of failures and even more fine-tuning. With this compound, these habits matter because of its role in advanced organic synthesis, pharmaceutical research, and, more specifically, as a key intermediate for calcium channel blocker manufacture.
Diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate has long been used as a core scaffold in heterocyclic chemistry. This class of pyridine derivatives proves attractive because they mimic natural cofactors in redox reactions, help unlock streamlined synthetic pathways, and, for those working in cardiovascular drug development, they link directly to the 1,4-dihydropyridine calcium antagonist family. Synthesizing this molecule in large volumes without sacrificing consistency tests the limits of batch plant engineering. Tiny drifts in temperature, off-gassing rates, or input purity result in unwanted byproducts that haunt downstream work—nobody wants to chase ghosts by column or worry about undetected isomers popping up in a final API. Each shipment shapes the trust between a manufacturer and a formulator or a bench scientist.
Producers who take shortcuts with nitrogen handling or who run condensation reactions on the wrong schedule face sluggish or runaway steps around the Knoevenagel condensation, which lies at the heart of this material’s synthesis route. During lab development, it’s easy to miss the quirks that only show up when blending diethyl acetoacetate, formaldehyde, ammonia sources, and methyl acetoacetate at scale. We’ve learned that controlled agitation and cooling don’t just stave off color body formation—they also control side reactions that would otherwise force increased post-process cleanup. Through feedback loops with users, we revisited purification, adopting additional liquid-liquid extraction steps and incremental changes to solvent systems. The result: measurable consistency and fewer impurities, saving trouble for those who use the compound downstream.
Talking about model or specifications sounds like tallying up numbers, but behind the typical technical data sheet lies a set of in-plant decisions that signal whether a producer prioritizes speed or long-run partnership. We validated spectral purity by NMR, established trace-by-trace impurity limits using HPLC, and ran accelerated stability studies across varied batch sizes. Our typical output exceeds 99% purity with moisture content consistently under 0.5%. We keep particle size moderate, with very little dust, helping bench chemists operate without loss and allowing pilot plant operators to blend and load without awkward bridging or adherence. Color remains pale yellow to off-white, crucial for those who use colorimetric endpoints. We surpass minimum purity demanded by most medicinal chemistry protocols, which eliminates rework and builds trust with process scale-up teams.
Most of our customers leverage diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate as an intermediate en route to more elaborate pyridine derivatives, especially in calcium antagonist drug pipelines and as building blocks for new materials research. It plays a critical part in producing substances like nisoldipine and nifedipine. Proper intermediate quality keeps transform chemistry reliable; deviations in residual solvent or unexpected minor byproducts foul catalysts during hydrogenation or cause irreproducible yields, which nobody can afford when running kilo lots intended for animal or toxicology studies.
We keep hearing from formulation scientists who have tested material from assorted global sources. Not every manufacturer tends the process with the same diligence. We've received feedback about competitors’ products showing variable melting points, residual odor, or strange hues—flags that something went off track during the reaction, workup, or even storage. These symptoms often trace back to uncontrolled condensation or insufficient drying cycles in the plant, or short-cuts taken in filtration. One customer reported having significant yield loss and increased processing times due to these hidden issues. Over the years we’ve hammered out a narrow range of acceptable process variations and invested in equipment upgrades to clamp down on these outliers, which puts our batches in a different league.
Controlling reaction heat profiles, sequencing addition of precursors, and choosing the right recovery solvents make all the difference when targeting high-purity dihydropyridine. We avoid quick fixes in favor of repeatable, well-documented process adjustments. It’s never about a once-for-all batch record— it’s dozens of internal reviews, mid-campaign check-ins, and willingness to course-correct based on actual analytical data. This deliberate approach pays off in the stability and shelf life our compound displays. Whether delivered in drum lots for preformulation or smaller batches for research, our track record of users reporting stable color and performance remains solid.
Chemists in pharma and biotech spaces spend enough of their working lives troubleshooting what went wrong. Time wasted on impure intermediates gets expensive. Our manufacturing team has sat through enough customer technical calls to know our real task isn’t just shipping kg after kg, but removing uncertainty from supply. This requires more than batch certificates and data publishing—it takes repeated interaction with end users, collecting actual performance feedback, and pushing for higher practical standards, even if the cost goes up as a result. Small investments in batch reproducibility prevent much bigger operational headaches downstream.
Laboratory oversight and strict in-process controls help us. We track pH, temperature, and TLC results every step. In a batch plant, real quality comes from the intersection of machinery upkeep, continuous staff training, and responsiveness to subtle changes in incoming raw material. Incoming solvents and precursors shape everything that follows. Tiny impurities in diethyl acetoacetate, for example, build up faster than one might guess and can throw off purity in the final lot. Seasoned staff recognize odd scents, shifts in viscosity, or color tints during early stages, triggering troubleshooting long before instrumentation flags a problem.
Side-by-side testing with samples from other plants has shown real, user-visible differences—not just a matter of paper spec sheets. Our long-term partners keep ordering our material after disappointing side experiments with alternative sources that generated more chromatography waste or failed to crystallize into the expected solid. The real cost of off-color or lower-purity compound comes in wasted efforts and degraded batch-to-batch reproducibility. Our lot retention samples, stored both at room temp and accelerated conditions, show long-term stability that most buyers cite only after months of warehouse storage. These details aren’t apparent at first glance but reveal themselves in real-world usage.
During bulk packaging, a powder’s density and flow matter. Our operators have learned through more than a few spills and headaches how delicate this compound can be to pack. Proper secondary containment and minimal headspace protect against caking or compaction. We avoid antistatic agents—and that’s based on hearing from one research partner that unexplained trace residues forced a requalification of their HPLC methods. Throughout the logistics chain, stability testing helps us know exactly how this intermediate will behave in cold or hot warehouses, and whether it will recover properly for downstream reactions. We maintain strict batch segregation to eliminate blending errors.
Pharmaceutical pilot plants thrive on comfort and predictability. Researchers have told us that the real advantage of well-manufactured diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate shows up on the day they decide to scale a medicinal chemistry process. If they know every shipment will perform the same way across months or years, they can plan scale-up around process parameters instead of batch-specific surprises. Customers share that high-purity, well-characterized intermediates support faster toxicological and PK screening, letting teams move more quickly from preclinical stage to candidate selection. By offering full transparency, open documentation, and follow-up support, we build confidence beyond just a price tag.
Analytical labs kept running control tests for unknown peaks during forced degradation studies of material supplied by lesser-equipped producers. We have revised our impurity fingerprint libraries over time based on user case studies and failed runs, to minimize unknowns. Specifically, elimination of aldehyde- or formyl-related byproducts reduced the frequency of chromatographic remediations needed at the customer site. Routine checks for moisture content let downstream chemical engineers avoid time-consuming pre-drying or filter cake remediation before starting further reactions. Each report from a customer about missed impurity control prompts another round of root-cause analysis at our plant, closing the feedback loop between data and process.
Medicinal chemistry teams on the race to a new drug candidate depend upon not just a molecule but its real-world consistency batch to batch. The wrong impurities at low levels may not show up in early trials, but they haunt scale-up, fouling further synthesis or even generating new toxicological worries. We’ve tracked customer outcomes for years, correlating repeat orders, new project launches, and process trouble tickets. Results show a clear pattern: investments in process control and in thorough documentation pay back in higher confidence and fewer lost development hours downstream. By aligning our process upgrades with user feedback, we make sure we don’t just meet a minimum standard but support full project success.
Producing diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate responsibly means more than minimizing waste or recycling solvents. We handle all effluents, vapor capture, and off-gassing to surpass regulatory standards. Our plant upgrades in recent years include better scrubber systems and in-line monitoring to prevent even trace-level odors, crucial for community relationships and workplace safety. Conversations with local regulatory review boards shaped several new practices. One team member who lives close to the fence line keeps us personally invested in the impact of our practices on the wider community. Tracking our environmental performance builds trust—inside and outside the industry.
Organizations advancing new materials, specialty coatings, and oxidative catalysis methods request this material for more than just drug-making. Some users seek specialized particle sizes or controlled residual solvent levels for specific device integration or polymer modification projects. Working directly with these teams helps us anticipate new challenges, such as meeting custom dryness targets or supporting novel crystallization regimes. By linking our know-how with emerging technical needs, we help bridge the gap between experimental concept and scalable reality in chemical development programs.
Complacency never helps. Each crop cycle, each campaign, brings data—sometimes in the form of production hiccups, sometimes as happy validation from end-users. We keep instrumentation calibrated. We compare analytical results month over month. Customer dialogue feeds our desire to keep advancing. As machine learning and predictive analytics take root in manufacturing, we pilot smarter monitoring tools and blend in staff expertise in detecting the patterns that still escape sensors or software. The best plants blend automation with the practical, hands-on troubleshooting that only experienced staff provide.
As research directions shift toward more sustainable, safer chemistries, the baseline expectations for all intermediates, including diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, have changed. Researchers require not only purity but verifiable provenance, renewable sourcing where possible, and clear chains of custody to support global compliance. These trends push everyone in the supply chain to step up. In our experience, openness to direct collaboration remains the best path—whether co-developing new grades, working on pilot programs with start-ups, or sharing insights from our own operational learning.
Years in chemical production have shown the difference true manufacturing discipline makes, especially across tightly regulated sectors like pharmaceuticals and specialty chemicals. Direct insight from lab bench, plant floor, and shipping dock all shape how we approach each batch. Our commitment to detail, transparency, and customer-driven feedback sets our material apart—not just on a spec sheet but in real-world results for the teams and products that depend on it. We look forward to continuing to support innovation with steady supply, proven know-how, and the ongoing dialogue that keeps all of us learning and improving.